PhD LIVE Study Fair

Oxford | Edinburgh | Sheffield

Coventry University Featured PhD Programmes
Sheffield Hallam University Featured PhD Programmes
Imperial College London Featured PhD Programmes
Engineering and Physical Sciences Research Council Featured PhD Programmes
University of Reading Featured PhD Programmes
United Kingdom ×
10 miles

Pharmacy / Pharmaceutics PhD Projects, Programs & Scholarships in the UK

We have 72 Pharmacy / Pharmaceutics PhD Projects, Programs & Scholarships in the UK

  • Pharmacy / Pharmaceutics×
  • United Kingdom×
  • clear all
Order by 
Showing 1 to 30 of 72
  EPSRC Centre for Doctoral Training in Engineered Tissues for Discovery, Industry and Medicine (LifETIME)

Funding Type

PhD Type

The CDT will train the next generation of leaders in developing in vitro tissues, sensing and diagnostics to develop humanised in vitro systems to drive better drug screening.
  Nanoparticles in drug delivery
  Dr G Stenbeck, Dr U Kishore
Applications accepted all year round

Funding Type

PhD Type

Nanoparticles (NPs) are materials with overall dimensions in the nano scale range (5nm-100nm). Due to their unique physicochemical properties, they have found a wide range of applications and are currently explored as drug and gene delivery vehicles.
  Could anti-inflammatory treatment at ACL reconstruction improve biological, functional and clinical outcomes?
  Dr D Mason, Prof C A Holt
Application Deadline: 14 November 2019

Funding Type

PhD Type

This project will test the hypothesis that inflammation after ACL reconstruction surgery is detectable in the joint fluids and blood, and reduces joint function and surgical outcomes; and that anti-inflammatory medication reduces inflammation and improves joint function and surgical outcomes.
  Discovery of novel cancer immunotherapeutic agents
  Dr Y Mehellou
Applications accepted all year round

Funding Type

PhD Type

Although cancer therapeutics, mainly chemotherapy and radiotherapy, have been extremely useful in the treatment of cancer, this disease is still associated with high morbidity and mortality.
  Discovery of novel treatments for Parkinson’s disease
  Dr Y Mehellou, Dr E Lane
Applications accepted all year round

Funding Type

PhD Type

Parkinson’s disease (PD) is the second most common neurological disease in the world. Current PD therapies and medical interventions are very limited and only address the symptoms of this disease highlighting the need for new and effective treatments.
  Prevention of Gestational Diabetes in Obese Pregnant Women; Targeting Early Pregnancy Intervention to Women at Risk
  Dr S White, Dr A Flynn
Applications accepted all year round

Funding Type

PhD Type

Obesity in pregnancy increases the risk of gestational diabetes (GDM) and associated adverse outcomes. NICE guidelines recommend that all obese women have an oral glucose tolerance test at 24-28 weeks' gestation for detection of GDM.
  Carbon nanotubes in the boron neutron capture therapy of cancer
  Dr G Calabrese
Applications accepted all year round

Funding Type

PhD Type

The early promise of boron neutron capture therapy as a method for the treatment of brain cancer has been mainly inhibited by the inherent toxicity associated with 10B-containing pharmacophores and the need for the ability to cross biological membranes.
  Intra-intestinal inactivation of residual antibiotics as a promising approach to fight against antimicrobial resistance.
  Dr M Khoder
Applications accepted all year round

Funding Type

PhD Type

Antimicrobial resistance (AMR) is a grave threat to public health causing 50000 deaths per year in the US and Europe alone. With virtually no new antibiotic classes created in the new millennia, identifying novel strategies to preserve and extend the useful life of existing antibiotics has therefore become a priority.
  Oral delivery of insulin for diabetes therapy: Development and evaluation of insulin loaded polymer/lipid based carrier systems
  Dr A Vangala
Applications accepted all year round

Funding Type

PhD Type

Diabetes is a chronic metabolic disorder that affects nearly 500 million people worldwide. Its hallmark feature, hyperglycaemia is caused due to insulin deficiency and/or resistance.
  3D printing of proteins for biopharmaceuticals
  Dr X Han
Application Deadline: 1 October 2019

Funding Type

PhD Type

The sales of biopharmaceuticals and biotherapy from only Humira, Remicade, and Enbrel are over $18 billion in US in 2015. Protein therapy is expected to make about $250 billion in savings for US over the next 10 years.
  Customised Drug Release by Additive Manufacturing
  Dr X Han
Application Deadline: 1 October 2019

Funding Type

PhD Type

To apply personalised medicine, as a customization of health care to individual patients, through linking personal diagnostics, can increase the effectiveness of the prescribed treatment regimen and to minimise their adverse effects.
  Cold Plasmas for Microbial Control in the Food Chain
  Dr B Gilmore, Dr P Flynn
Application Deadline: 30 September 2019

Funding Type

PhD Type

The ability to generate plasmas (quasi-neutral, wholly or partially ionised gases) at ambient or tissue tolerable temperatures has given rise to the nascent field of plasma medicine.
  Molecular interactions in solution for multi-component crystallisation
  Dr K Edkins, Dr J Holbrey
Applications accepted all year round

Funding Type

PhD Type

Crystallisation is probably one of the most important unit operations in pharmaceutical industry for purification, as well as the generation of materials appropriate for formulation and application to the patient.
  The effect of female sex hormones on hearing and tinnitus.
  Dr K Kluk
Applications accepted all year round

Funding Type

PhD Type

Sex hormones fluctuate in level in women, both during the lifespan and during the ovarian cycle. Recent research suggests that oestrogen is neuroprotective, and may affect auditory function.
  Analysing the factors that regulate expression of blood-brain barrier drug transporter proteins
  Dr J L Penny, Dr C Demonacos
Applications accepted all year round

Funding Type

PhD Type

In order to treat diseases associated with the central nervous system (CNS), e.g. cancer, Parkinson’s disease, depression, it is essential for therapeutic drugs to be able to penetrate into the brain.
  Is there a switch between prostamides and prostaglandins in women with dysmenorrhoea and heavy menstrual bleeding?
  Prof K Marshall, Dr D Fischer, Prof A Nicolaou
Applications accepted all year round

Funding Type

PhD Type

Dysmenorrhoea, painful menstrual cramps, and heavy menstrual bleeding are common debilitating symptoms in women with or without an underlying pelvic pathology.
  Structure based design of novel warheads for use in peptide-drug conjugates
  Dr S Butterworth, Dr A Tirella, Dr D Wiseman
Applications accepted all year round

Funding Type

PhD Type

Chronic Myelomonocytic Leukaemia (CMML) is an orphan disease defined by myeloid dysplasia, myeloproliferation and a malignant expansion of classical monocytes.
  15 fully-funded 4-year PhD studentships in the EPSRC Centre for Doctoral Training in Transformative Pharmaceutical Technologies

Funding Type

PhD Type

Funded by the Engineering and Physical Sciences Council, Science Foundation Ireland and 19 industry partners, the EPSRC Centre for Doctoral Training (CDT) in Transformative Pharmaceutical Technologies provides world-leading training to prepare strategic-thinking scientists for high achieving careers in the pharmaceutical and healthcare sectors.
  A novel approach to the development of an antimuscarinic potency tool and measuring anticholinergic burden in older people
  Dr P Nishtala
Applications accepted all year round

Funding Type

PhD Type

A self-funded PhD studentship is available under the supervision of Dr Prasad Nishtala at the University of Bath. This is a collaborative project which will involve working with Dr Hamish Jamieson from the Big Data and Ageing Research Group at Christchurch.
  An Organ on a Chip Platform for Biomedical Applications
  Dr P De Bank
Applications accepted all year round

Funding Type

PhD Type

Organ on a chip devices are an emerging technology which employ microfluidics to grow 3D tissues, mimicking the physiological conditions found in vivo.
  Bioactive Scaffolds for Tissue Engineering and Regenerative Medicine
  Dr P De Bank
Applications accepted all year round

Funding Type

PhD Type

Tissue engineering and regenerative medicine aim to either replace diseased or damaged tissue with a functional, laboratory-grown substitute, or stimulate the body’s own cells in order to promote repair.
  Examining the longitudinal associations of polypharmacy and frailty with functional decline in older people with multimorbidity
  Dr P Nishtala
Applications accepted all year round

Funding Type

PhD Type

A self-funded PhD studentship is available under the supervision of Dr Prasad Nishtala at the University of Bath. This is a collaborative project, which will involve working with Dr Hamish Jamieson from the Big Data and Ageing Research Group at Christchurch and Dr Danijela Gnjidic at the University of Sydney.
  Pharmacoepidemiological study to systematically investigate drug-related adverse events in older people
  Dr P Nishtala
Applications accepted all year round

Funding Type

PhD Type

A self-funded PhD studentship is available under the supervision of Dr Prasad Nishtala at the University of Bath. This is a collaborative project which will involve working with Dr Hamish Jamieson from the Big Data and Ageing Research Group at Christchurch, NZ.
  EPSRC Centre for Doctoral Training in Engineered Tissues for Discovery, Industry and Medicine (LifETIME)

Funding Type

PhD Type

The CDT will train the next generation of leaders in developing in vitro tissues, sensing and diagnostics to develop humanised in vitro systems to drive better drug screening.
  Biodegradable composite materials (Bio-PolyMOFs) for applications in targeted delivery of drugs to improve healthcare and reduce antimicrobial resistance in developing countries and worldwide
  Research Group: Chemistry and Biosciences
  Dr S Nayak, Dr A L Kelly, Dr M Katsikogianni
Applications accepted all year round

Funding Type

PhD Type

Growing antimicrobial resistance (AMR) is one of the major global challenges and is linked to the use of unnecessarily high doses of orally administered antibiotics following medical surgery and infections.
  Formulation and evaluation of umbilical cord-derived mesenchymal stem cells exosomes and antioxidants, incorporated in nanoliposomes using microfluidics, for the treatment of solid tumours
  Research Group: Chemistry and Biosciences
  Dr M Najafzadeh, Prof D Anderson, Dr M Isreb
Applications accepted all year round

Funding Type

PhD Type

This project uses the Cord blood Stem Cells from healthy control and the white blood cells of blood cancer patients to investigate the efficacy and genotoxicity of different compounds in them by using various genetic endpoints.
  Ion channel gating kinetics and structure implication for drug delivery
  Research Group: Chemistry and Biosciences
  Dr L Shang, Dr Z Hughes
Applications accepted all year round

Funding Type

PhD Type

Ion channels are proteins which sit in the membrane of every cell in the body and control the flow of positively charged ions such as sodium and potassium into and out of the cell.
  Investigation of the impact of a student-centred pharmacy curriculum delivered predominantly by Team-Based Learning (TBL) Using a Mixed Methods Approach
  Research Group: Education Innovation Research and Development
  Dr S Jones, Dr S Twedell, Dr S McLean
Applications accepted all year round

Funding Type

PhD Type

Some would consider that there is a misalignment between educational practice and educational research with a high reliance of content delivery and less on information processing.
  Activity based proteomic probes for profiling CYP2W1 in cancer tissues
  Research Group: Institute of Cancer Therapeutics
  Dr C Sutton, Dr K Pors
Applications accepted all year round

Funding Type

PhD Type

Cytochromes P450 (CYPs) are a superfamily of mixed function oxidases of which CYP1-4 subfamily members are unique in their ability to oxidise drugs.
  Design, synthesis and evaluation of protease-activated anti-cancer prodrugs
  Research Group: Institute of Cancer Therapeutics
  Dr R Falconer, Prof P Loadman
Applications accepted all year round

Funding Type

PhD Type

Matrix metalloproteinases (MMPs) are a family of endoproteases that are overexpressed in tumours and play crucial roles in many tumourigenic processes, not least tumour invasion and angiogenesis.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.